Transaction prior to Revenaz. Led by Revenaz's responsible partner at Âncora Capital, where he was sole senior partner between 2017 and 2024, before founding Revenaz.


Drogarias Nissei raised debt through a convertible debenture with Farallon Capital
Context
Nissei is one of the leading pharmacy chains in Paraná. Farallon Capital is a global alternative investment manager active in structured credit.
Transaction rationale
The convertible debenture combined the cost of debt with an option to convert into equity, aligning the investor with the chain's growth without immediate dilution of the controlling shareholders.
How the transaction is structured
How a transaction of this type works and what it is built on.
- A debenture paying interest with an option to convert into shares at a price or formula set in the indenture.
- Private placement or restricted offering to a professional investor, typically with a three to six year tenor.
- Indenture with financial covenants, events of default and events that trigger early conversion, such as a change of control or an IPO.
- Real or personal guarantees and, in general, a fiduciary assignment of receivables as additional security.
Where the transaction is decided
- The conversion price sets the maximum dilution of the controlling shareholders and is the most negotiated term.
- Anti-dilution and conversion price adjustment clauses can transfer value to the investor in later rounds.
- The effective cost must add interest, the implicit option premium and structuring costs.
Revenaz's responsible partner, then at Âncora Capital, advised Nissei on structuring and negotiating the raise.
Transaction led by Revenaz's responsible partner at Âncora Capital, where he was sole senior partner between 2017 and 2024.
Speak with the responsible partner
There is no screening. The conversation begins and ends with the person running the transaction